Zyus Life Sciences Corp. logo

Zyus Life Sciences Corp. (ZYUS)

Market Open
7 Aug, 20:00
TSX-V TSX-V
CA$
0. 50
0
0%
CA$
- Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
CA$ 0.5
Previous Close
Add Transaction
Day Range
0.5 0.5
Year Range
0.4 0.74
Want to track ZYUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ZYUS trading today higher at CA$0.5, an increase of 0% from yesterday's close, completing a monthly increase of 0% or CA$0. Over the past 12 months, ZYUS stock lost -26.4706%.
ZYUS is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0.05%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

ZYUS Chart

Zyus Life Sciences Corp. (ZYUS) FAQ

What is the stock price today?

The current price is CA$0.50.

On which exchange is it traded?

Zyus Life Sciences Corp. is listed on TSX-V.

What is its stock symbol?

The ticker symbol is ZYUS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Zyus Life Sciences Corp. ever had a stock split?

No, there has never been a stock split.

Zyus Life Sciences Corp. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Brent H. Zettl CEO
TSX-V Exchange
CA9899601095 ISIN
Canada Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

ZYUS Life Sciences Corporation is a pioneering firm in the phyto-therapeutic and cannabis-based medicine industry with global operations. Since its incorporation in 1944, ZYUS has been committed to the development, manufacture, and distribution of cannabinoid-based therapeutics and products. The company prides itself on its innovative approach to healthcare, aiming to enhance the quality of life for patients worldwide. Operating out of Saskatoon, Canada, ZYUS Life Sciences Corporation leverages its extensive experience and research capabilities to deliver high-quality, effective solutions in the realm of cannabinoid medicine.

Products and Services

  • Oils:
  • ZYUS Life Sciences Corporation offers a variety of cannabinoid-based oils, designed to provide patients with precise dosing options for oral consumption. These oils are formulated to ensure high purity and consistency, aiming to offer relief and therapeutic benefits for various conditions.

  • Gel-Caps:
  • The company produces gel-caps as an alternative to traditional oral cannabinoid applications. These gel-caps provide a convenient, discreet, and easy-to-use option for medication intake, ensuring consistent dosage and efficacy for patients seeking pain relief, anti-inflammatory effects, or other therapeutic benefits associated with cannabinoids.

  • Topical Creams:
  • Additionally, ZYUS offers topical creams infused with cannabinoids for patients preferring localized treatment options. These creams are designed to target specific areas of discomfort, providing relief from pain and inflammation without the systemic effects associated with oral medications. This product line reflects ZYUS's commitment to diversifying its offerings to meet the unique needs of its customer base.

Contact Information

Address: Unit 204
Phone: 888 651 9987